NEUROCRINE BIOSCIENCES INC Contracts & Agreements

119 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Commercial Lease dated February 8, 2022, by and between the Company and Gemdale Aperture Phase I, LLC
Lease Agreements
NEUROCRINE BIOSCIENCES INC
Biotechnology
2022
Form of Restricted Stock Unit Award Grant Notice and Restricted Stock Unit Award Agreement for grants on or after February 13, 2024 made under the Neurocrine Biosciences, Inc....
Bonus & Incentive Agreements
NEUROCRINE BIOSCIENCES INC
2024
Form of Stock Option Grant Notice and Option Agreement for grants made to Kevin Gorman on or after February 13, 2024 made under the Neurocrine Biosciences, Inc. 2020 Equity...
Bonus & Incentive Agreements
NEUROCRINE BIOSCIENCES INC
2024
Neurocrine Biosciences, Inc. 2020 Equity Incentive Plan, as amended and restated
Bonus & Incentive Agreements
NEUROCRINE BIOSCIENCES INC
2023
Employment Agreement dated November 29, 2021 between the Company and Jude Onyia
Employment Agreements
NEUROCRINE BIOSCIENCES INC
2022
Neurocrine Biosciences, Inc. 2020 Equity Incentive Plan, as amended
Bonus & Incentive Agreements
NEUROCRINE BIOSCIENCES INC
2022
Neurocrine Biosciences, Inc. 2018 Employee Stock Purchase Plan, as amended
Stock Agreements
NEUROCRINE BIOSCIENCES INC
Biotechnology
2022
First Supplemental Indenture, dated as of December 22, 2021, by and between the Company and U.S. Bank National Association, as Trustee
Indenture Agreements
NEUROCRINE BIOSCIENCES INC
Biotechnology
NY
2022
Collaboration and License Agreement dated November 22, 2021 between Heptares Therapeutics Limited and the Company
Collaboration Agreements
NEUROCRINE BIOSCIENCES INC
2022
Form of Stock Option Grant Notice and Option Agreement for use under the Neurocrine Biosciences, Inc. 2020 Equity Incentive Plan, and Form of Restricted Stock Unit Award Grant...
Bonus & Incentive Agreements
NEUROCRINE BIOSCIENCES INC
Biotechnology
2022
Collaboration Agreement dated June 15, 2010, by and between Abbott International Luxembourg S.a.r.l. and the Company as amended on August 31, 2011
Collaboration Agreements
NEUROCRINE BIOSCIENCES INC
2021
First Amendment to Collaboration and License Agreement Dated August 31, 2011 between the Company and Abbott International Luxembourg S.a.r.l
Collaboration Agreements
NEUROCRINE BIOSCIENCES INC
2021
Collaboration and License Agreement dated March 31, 2015 between Mitsubishi Tanabe Pharma Corporation and the Company
Collaboration Agreements
NEUROCRINE BIOSCIENCES INC
Biotechnology
NY
2021
License Agreement dated February 9, 2017 between BIAL- Portela & CA, S.A. and the Company
License Agreements
NEUROCRINE BIOSCIENCES INC
Biotechnology
2021
Neurocrine Biosciences, Inc. 2020 Equity Incentive Plan
Bonus & Incentive Agreements
NEUROCRINE BIOSCIENCES INC
2020
Form of Stock Option Grant Notice and Option Agreement for use under the Neurocrine Biosciences, Inc. 2020 Equity Incentive Plan, and Form of Restricted Stock Unit Award Grant...
Bonus & Incentive Agreements
NEUROCRINE BIOSCIENCES INC
Biotechnology
2020
Description of Common Stock of the Company
Stock Agreements
NEUROCRINE BIOSCIENCES INC
Biotechnology
2020
Employment Agreement dated November 3, 2014 between the Company and Kyle Gano
Employment Agreements
NEUROCRINE BIOSCIENCES INC
Biotechnology
CA
2020
Third Amendment to Amended and Restated Lease between the Company and Kilroy Realty, L.P. dated August 7, 2019
Lease Agreements
NEUROCRINE BIOSCIENCES INC
2019
Amendment No. 1 to Collaboration and License Agreement dated June 14, 2019 between Voyager Therapeutics, Inc. and the Company
Collaboration Agreements
NEUROCRINE BIOSCIENCES INC
Biotechnology
2019
Employment Agreement dated January 8, 2018 between the Company and Eiry W. Roberts, M.D
Employment Agreements
NEUROCRINE BIOSCIENCES INC
2019
Neurocrine Biosciences, Inc. Inducement Plan, as amended
NEUROCRINE BIOSCIENCES INC
Biotechnology
CA
2018
Employment Agreement effective November 29, 2017 between the Company and Matt Abernethy
Employment Agreements
NEUROCRINE BIOSCIENCES INC
Biotechnology
CA
2018
Form of Indemnity Agreement entered into with each of the Companys executive officers and directors
NEUROCRINE BIOSCIENCES INC
2017
Amended and Restated Product Agreement dated June 27, 2017 by and between Patheon UK Limited and the Company
NEUROCRINE BIOSCIENCES INC
2017
Second Amendment to Amended and Restated Lease dated October 12, 2017 between Kilroy Realty, L.P. and the Company
Lease Agreements
NEUROCRINE BIOSCIENCES INC
Biotechnology
2017
FIRST AMENDMENT TO AMENDED AND RESTATED LEASE
Lease Agreements
NEUROCRINE BIOSCIENCES INC
Biotechnology
2017
Amendment To Irrevocable Standby Letter Of Credit
Credit Agreements
NEUROCRINE BIOSCIENCES INC
Biotechnology
2017
NEUROCRINE BIOSCIENCES, INC. and U.S. BANKNATIONAL ASSOCIATION as Trustee INDENTURE Dated as of May 2, 2017 2.25%Convertible Senior Notes due 2024 TABLE OF CONTENTS
Indenture Agreements
NEUROCRINE BIOSCIENCES INC
2017
EMPLOYMENT AGREEMENT
Employment Agreements
NEUROCRINE BIOSCIENCES INC
2017
EMPLOYMENT AGREEMENT
Employment Agreements
NEUROCRINE BIOSCIENCES INC
2017
Neurocrine Biosciences, Inc. 12780 El Camino Real San Diego, CA 92130
NEUROCRINE BIOSCIENCES INC
Biotechnology
CA
2017
COLLABORATION AGREEMENT dated June 15, 2010 by and between AbbottInternational Luxembourg S.à r.l. and Neurocrine Biosciences, Inc. EXHIBIT INDEX
Collaboration Agreements
NEUROCRINE BIOSCIENCES INC
2016
NEUROCRINE BIOSCIENCES, INC. INDUCEMENT PLAN ADOPTED: SEPTEMBER 15, 2014 AMENDED: OCTOBER 7, 2014 AMENDED: APRIL 29, 2015
NEUROCRINE BIOSCIENCES INC
Biotechnology
CA
2015
COLLABORATION AND LICENSE AGREEMENT
Collaboration Agreements
NEUROCRINE BIOSCIENCES INC
2015
6,944,000 Shares NEUROCRINE BIOSCIENCES, INC. Common Stock ($0.001par value per Share) UNDERWRITING AGREEMENT
Underwriting Agreements
NEUROCRINE BIOSCIENCES INC
2015
Irrevocable Letter of Credit
Credit Agreements
NEUROCRINE BIOSCIENCES INC
2015
NEUROCRINE BIOSCIENCES, INC. INDUCEMENT PLAN ADOPTED: SEPTEMBER 15, 2014 AMENDED: OCTOBER 7, 2014
NEUROCRINE BIOSCIENCES INC
2014
NEUROCRINE BIOSCIENCES, INC. 2011 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS:FEBRUARY 21, 2011 APPROVED BY THESTOCKHOLDERS: MAY 25, 2011 AMENDED BYTHE STOCKHOLDERS:...
Bonus & Incentive Agreements
NEUROCRINE BIOSCIENCES INC
Biotechnology
CA
2014
8,000,000 Shares NEUROCRINE BIOSCIENCES, INC. Common Stock ($0.001 parvalue per Share) UNDERWRITING AGREEMENT
Underwriting Agreements
NEUROCRINE BIOSCIENCES INC
Biotechnology
NY
2014
NONEXCLUSIVE LICENSE AGREEMENT
License Agreements
NEUROCRINE BIOSCIENCES INC
Biotechnology
NY
2013
NEUROCRINE BIOSCIENCES, INC. 2011 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS:FEBRUARY 21, 2011 APPROVED BY THESTOCKHOLDERS: MAY 25, 2011 AMENDED BYTHE STOCKHOLDERS:...
Bonus & Incentive Agreements
NEUROCRINE BIOSCIENCES INC
2013
9,500,000 Shares NEUROCRINE BIOSCIENCES, INC. Common Stock ($0.001 par value per Share) UNDERWRITING AGREEMENT
Underwriting Agreements
NEUROCRINE BIOSCIENCES INC
Biotechnology
NY
2012
NEUROCRINE BIOSCIENCES, INC. 2011 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS:FEBRUARY 21, 2011 APPROVED BY THESTOCKHOLDERS: MAY 25, 2011 TERMINATION DATE:FEBRUARY 20,...
Bonus & Incentive Agreements
NEUROCRINE BIOSCIENCES INC
Biotechnology
CA
2011
AMENDMENT TO EMPLOYMENT AGREEMENT
Employment Agreements
NEUROCRINE BIOSCIENCES INC
2011
Contract Number: 43031148 COLLABORATION AND LICENSE AGREEMENT Dated June 16, 2010 BY AND BETWEEN BOEHRINGER INGELHEIM INTERNATIONAL GmbH AND NEUROCRINE BIOSCIENCES, INC. TABLE OF...
Collaboration Agreements
NEUROCRINE BIOSCIENCES INC
Biotechnology
CA
2010
COLLABORATION AGREEMENT dated June 15, 2010 by and between Abbott International Luxembourg S.à r.l. and Neurocrine Biosciences, Inc.
Collaboration Agreements
NEUROCRINE BIOSCIENCES INC
2010
9,100,000 Shares NEUROCRINE BIOSCIENCES, INC. Common Stock ($0.001 par value per Share) UNDERWRITING AGREEMENT
Underwriting Agreements
NEUROCRINE BIOSCIENCES INC
2010
SECOND AMENDMENT TO LEASE
Lease Agreements
NEUROCRINE BIOSCIENCES INC
Biotechnology
2009
REGISTRATION RIGHTS AGREEMENT
Registration Rights Agreements
NEUROCRINE BIOSCIENCES INC
2009
COMMON STOCK PURCHASE AGREEMENT
Stock Agreements
NEUROCRINE BIOSCIENCES INC
Biotechnology
DE
2009
FINANCIAL STATEMENTS
NEUROCRINE BIOSCIENCES INC
2009
Target Indication
NEUROCRINE BIOSCIENCES INC
Biotechnology
2009
Current assets
NEUROCRINE BIOSCIENCES INC
2008
Target Indication
NEUROCRINE BIOSCIENCES INC
Biotechnology
NY
2008
Target Indication
NEUROCRINE BIOSCIENCES INC
2008
Target Indication
NEUROCRINE BIOSCIENCES INC
Biotechnology
CA
2008
Target Indication
NEUROCRINE BIOSCIENCES INC
Biotechnology
CA
2008
Target Indication
NEUROCRINE BIOSCIENCES INC
2008
Fifth Amendment to Purchase Agreement and Escrow Instructions dated December 3, 2007, among Neurocrine Biosciences, Inc., Science Park Center LLC and DMH Campus Investors, LLC
Escrow Agreements
NEUROCRINE BIOSCIENCES INC
Biotechnology
2007
Fifth Amendment to Purchase Agreement and Escrow Instructions dated December 3, 2007, among Neurocrine Biosciences, Inc., Science Park Center LLC and DMH Campus Investors, LLC
Escrow Agreements
NEUROCRINE BIOSCIENCES INC
Biotechnology
CA
2007
Fifth Amendment to Purchase Agreement and Escrow Instructions dated December 3, 2007, among Neurocrine Biosciences, Inc., Science Park Center LLC and DMH Campus Investors, LLC
Escrow Agreements
NEUROCRINE BIOSCIENCES INC
2007
Current assets
NEUROCRINE BIOSCIENCES INC
Biotechnology
CA
2007
Current assets
NEUROCRINE BIOSCIENCES INC
Biotechnology
DE
2007
Current assets
NEUROCRINE BIOSCIENCES INC
Biotechnology
CA
2007
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
NEUROCRINE BIOSCIENCES INC
2007
Current assets
NEUROCRINE BIOSCIENCES INC
2007
Current assets
NEUROCRINE BIOSCIENCES INC
Biotechnology
CA
2007
Current assets
NEUROCRINE BIOSCIENCES INC
Biotechnology
CA
2007
Current assets
NEUROCRINE BIOSCIENCES INC
2007
Current assets
NEUROCRINE BIOSCIENCES INC
2007
Current assets
NEUROCRINE BIOSCIENCES INC
Biotechnology
CA
2007
Current assets
NEUROCRINE BIOSCIENCES INC
2007
Neurocrine Biosciences, Inc. 2003 Incentive Stock Plan, as amended
Bonus & Incentive Agreements
NEUROCRINE BIOSCIENCES INC
Biotechnology
2007
Target Indication
NEUROCRINE BIOSCIENCES INC
2007
On December 21, 2006, the Company announced that Wendell Wierenga, Ph.D, Executive Vice President of Research and Development has resigned from the Company. Dr. Wierenga will...
Development Agreements
NEUROCRINE BIOSCIENCES INC
Biotechnology
CA
2006
Current assets
NEUROCRINE BIOSCIENCES INC
2006
AMENDED AND RESTATED EMPLOYMENT AGREEMENT
Employment Agreements
NEUROCRINE BIOSCIENCES INC
Biotechnology
CA
2006
EMPLOYMENT AGREEMENT
Employment Agreements
NEUROCRINE BIOSCIENCES INC
Biotechnology
CA
2006
Current assets
NEUROCRINE BIOSCIENCES INC
Biotechnology
2006
Current assets
NEUROCRINE BIOSCIENCES INC
Biotechnology
2006
Amended agreement with GlaxoSmithKline dated February 7, 2006
NEUROCRINE BIOSCIENCES INC
2006
Target Indication
NEUROCRINE BIOSCIENCES INC
2006
Exhibit No
NEUROCRINE BIOSCIENCES INC
2006
Exhibit No
NEUROCRINE BIOSCIENCES INC
2006
Description of Exhibit
NEUROCRINE BIOSCIENCES INC
2005
Description of Exhibit
NEUROCRINE BIOSCIENCES INC
2005
EXHIBITS. The following exhibits are
NEUROCRINE BIOSCIENCES INC
Biotechnology
CA
2005
Description of Exhibit
NEUROCRINE BIOSCIENCES INC
Biotechnology
CA
2005
Description of Exhibit
NEUROCRINE BIOSCIENCES INC
Biotechnology
CA
2005
Target Indication
NEUROCRINE BIOSCIENCES INC
2005
Target Indication
NEUROCRINE BIOSCIENCES INC
Biotechnology
CA
2005
Current assets
NEUROCRINE BIOSCIENCES INC
Biotechnology
DE
2004
Current assets
NEUROCRINE BIOSCIENCES INC
Biotechnology
CA
2004
Legal Proceedings
NEUROCRINE BIOSCIENCES INC
Biotechnology
CA
2004
Legal Proceedings
NEUROCRINE BIOSCIENCES INC
Biotechnology
CA
2004
Legal Proceedings
NEUROCRINE BIOSCIENCES INC
Biotechnology
CA
2004
FINANCIAL INFORMATION
NEUROCRINE BIOSCIENCES INC
2003
FINANCIAL INFORMATION
NEUROCRINE BIOSCIENCES INC
2003
FINANCIAL INFORMATION
NEUROCRINE BIOSCIENCES INC
2003
FINANCIAL INFORMATION
NEUROCRINE BIOSCIENCES INC
2003
FINANCIAL INFORMATION
NEUROCRINE BIOSCIENCES INC
Biotechnology
DE
2003
FINANCIAL INFORMATION
NEUROCRINE BIOSCIENCES INC
Biotechnology
WA
2003
Exhibit Number
NEUROCRINE BIOSCIENCES INC
Biotechnology
NY
2003
FINANCIAL INFORMATION
NEUROCRINE BIOSCIENCES INC
Biotechnology
CA
2003
FINANCIAL INFORMATION
NEUROCRINE BIOSCIENCES INC
2003
FINANCIAL INFORMATION
NEUROCRINE BIOSCIENCES INC
Biotechnology
2003
FINANCIAL INFORMATION
NEUROCRINE BIOSCIENCES INC
Biotechnology
2003
FINANCIAL INFORMATION
NEUROCRINE BIOSCIENCES INC
Biotechnology
2003
FINANCIAL INFORMATION
NEUROCRINE BIOSCIENCES INC
2003
FINANCIAL INFORMATION
NEUROCRINE BIOSCIENCES INC
2003
FINANCIAL INFORMATION
NEUROCRINE BIOSCIENCES INC
2003
FINANCIAL INFORMATION
NEUROCRINE BIOSCIENCES INC
Biotechnology
DE
2003
Legal Proceedings
NEUROCRINE BIOSCIENCES INC
2003
Legal Proceedings
NEUROCRINE BIOSCIENCES INC
Biotechnology
CA
2004
Legal Proceedings
NEUROCRINE BIOSCIENCES INC
Biotechnology
CA
2004
Legal Proceedings
NEUROCRINE BIOSCIENCES INC
2003
Exhibit Number
NEUROCRINE BIOSCIENCES INC
Biotechnology
NY
2002
Exhibit Number
NEUROCRINE BIOSCIENCES INC
Biotechnology
NY
2002